HeLa cells

ArtNr	C0008001
Hersteller	Addexbio
Menge	One Frozen vial
Kategorie	Oncology Metabolism Diabetes Glucose Homeostasis Cell Lines & Cell Culture Cell Lines By Organ Lung Cancer Breast Cancer Uterine, Ovarian & Cervical Cancer
Typ	Tumour Cells
Specific against	Human (Homo sapiens)
Dry ice	Yes
Citations	1.Bulotta, S., Ierardi, M. V., Maiuolo, J., Cattaneo, M. G., Cerullo, A., Vicentini, L. M., and Borgese, N. Basal nitric oxide release attenuates cell migration of HeLa and endothelial cells. Biochem Biophys Res Commun, 386: 744-749, 2009. 2.Hsu, Y. L., Chia, C. C., Chen, P. J., Huang, S. E., Huang, S. C., and Kuo, P. L. Shallot and licorice constituent isoliquiritigenin arrests cell cycle progression and induces apoptosis through the induction of ATM/p53 and initiation of the mitochondrial system in human cervical carcinoma HeLa cells. Mol Nutr Food Res, 53: 826-835, 2009. 3.Ueno, T. and Takahashi, K. A cathepsin L-specific inhibitor preferentially inhibits degradation of autophagosomal LC3 and GABARAP in HeLa and Huh-7 cells. Autophagy, 5: 878-879, 2009. 4.Kugawa, F., Suzuki, T., Miyata, M., Tomono, K., and Tamanoi, F. Construction of a model cell line for the assay of MDR1 (multi drug resistance gene-1) substrates/inhibitors using HeLa cells. Pharmazie, 64: 296-300, 2009. 5.Cheng, M. H., Cheng, H. T., Lin, S. S., Young, S. C., Pai, C. J., Liao, P. H., Chen, S. C., Chou, M. Y., Yang, J. J., and Yang, C. C. Apoptotic death mode of mitomycin C-treated HeLa cells and cellular localization of mitomycin C-induced P-glycoprotein. Drug Chem Toxicol, 32: 158-168, 2009. 6.Han, Y. H., Moon, H. J., You, B. R., and Park, W. H. The effect of MG132, a proteasome inhibitor on HeLa cells in relation to cell growth, reactive oxygen species and GSH. Oncol Rep, 22: 215-221, 2009. 7.Ito, T., Oshita, S., Nakabayashi, T., Sun, F., Kinjo, M., and Ohta, N. Fluorescence lifetime images of green fluorescent protein in HeLa cells during TNF-alpha induced apoptosis. Photochem Photobiol Sci, 8: 763-767, 2009.
ECLASS 10.1	32160890
ECLASS 11.0	32160890
UNSPSC	41106509
Lieferbar
Description	Disease: Cervical adenocarcinoma Origin: Derived from a cervical carcinoma Species: Homo sapiens Tissue: Cervix Morphology: Epithelial Properties: Adherent Cytogenic data: Tumorigenic; aneuploid Patient: Female, Black, 31 yrs of age Medium: MEM + 10% FBS Subculture: 1:2 TO 1:6 using 0.25% trypsin or trypsin/EDTA, 5% CO2; 37C Freezing Medium: Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: II Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative Protein Expression: keratin Isoenzymes: G6PD, A DNA Profile (STR): Amelogenin: X CSF1PO: 9, 10 D13S317: 12, 13.3 D16S539: 9, 10 D5S818: 11, 12 D7S820: 8, 12 THO1: 7 TPOX: 8, 12 vWA: 16, 18 Related cells by Organ: HEC-59 cells HeLa cells SiHa cells CaSKi cells C33A cells
Storage condition	LN2
Manufacturer - Category	Cell Lines

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Arbeitsanleitung (Data Sheet) anfordern

Produkt-Datenblatt anfordern

Sicherheitsdatenblatt anfordern

Einfache Bestellung Periodische Bestellung

Menge: One Frozen vial

lieferbar

Lieferung vsl. bis 08.01.2026

Express-Lieferung: 13 Tage sparen

Vergleichen

Auf den Wunschzettel

Angebot anfordern